Sanofi appoints David Loew, Senior Vice President, Commercial Operations, Europe

Sanofi (EURONEXT : SAN and NYSE : SNY) is pleased to announce today the appointment of David Loew, as Senior Vice President, Commercial Operations, Europe, effective July 1st , 2013. He will report to Peter Guenter in his new role as Executive Vice President, Global Commercial Operations. David will join the Global Leadership Team and become Chairman of the European Strategic Committee.

As Senior Vice President, Commercial Operations, Europe, David Loew will be responsible for 38 countries organized into direct countries and Multi Country Organizations. David will be responsible for defining the commercial strategy for the region and lead its effective execution through more than 9,000 employees.

Peter Guenter, currently Senior Vice President, Europe, Sanofi declared: “Europe remains a key strategic region for Sanofi, with a high level of complexity and diversity of markets, facing critical challenges in a mature environment. David’s vast experience, international exposure and know how at both country and corporate positions will be a significant addition to Sanofi and make him ideally suited to lead our commercial operations in Europe.”

David Loew will join Sanofi from Roche Pharmaceuticals where he is currently Regional Head Eastern Europe, Middle East and Africa.

Biography of David Loew

Swiss born, David Loew, started his career with traineeships in the US at Coopers & Lybrand and Hewlett Packard in 1990, before joining Roche in 1992 as a sales representative in Vienna, Austria. He moved to Basel in 1993 for a management development programme and then took up the position of Senior Product Manager in France in 1995. Within two years, David was promoted to Marketing Manager for transplantation and dialysis. In 1999 he was appointed Business Director, Specialty Care in Mexico.

David was promoted in 2001 to global marketing roles – “Life Cycle Leader” – of growing importance, splitting his time between Nutley, New Jersey and Basel, Switzerland. He was instrumental in developing and launching several indications of Xeloda and MabThera shaping the drugs successes. Subsequently David took over the position as Oncology head.

After six years in marketing roles, David became General Manager Switzerland in 2007 and at the beginning of 2010, was appointed Global Chief Marketing Officer / Head of Global Product Strategy for the pharmaceuticals division of Roche. His remit included the responsibility for all therapeutic areas of Roche, including the area heads, life cycle and global brand teams, the global medical affairs function, global pharmaceuticals economics and pricing. In early 2013, he was appointed to his current role as Regional Head Eastern Europe, Middle East and Africa.

David has a degree in Finance and Marketing and an MBA from the University of St. Gallen (HSG). German is David’s native tongue and he speaks English, French and Spanish fluently.